search
Back to results

Effect of Preoperative Tramadol and Naproxen Sodium on Post Operative Pain

Primary Purpose

Symptomatic Irreversible Pulpitis, Post Operative Pain

Status
Completed
Phase
Phase 2
Locations
Pakistan
Study Type
Interventional
Intervention
Tramadol
Naproxen Sodium
Placebo
Sponsored by
Dow University of Health Sciences
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Symptomatic Irreversible Pulpitis focused on measuring Tramadol, Naproxen Sodium, Placebo

Eligibility Criteria

18 Years - 60 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria: ASA I and ASA II individuals who are between the ages of 18 and 60 years. Patients who have been diagnosed with symptomatic irreversible pulpitis (with either a normal periapex or symptomatic apical periodontitis). Patients who score moderate to severe (4-10) on a preoperative visual analogue scale (VAS= 1-10). Mandibular permanent premolar and molars. Exclusion Criteria: Patients who had taken painkillers or narcotics in the previous 12 hours Patients suffering from severe pain because of traumatic occlusion. Teeth with extensive damage, calcified canals, root resorption, and an open apex. Previously root canal treated teeth. Medically compromised patients (ASA-III and above) Those with special communication needs or who do not understand Urdu or English language. Pregnant and lactating women Individual patients who will be driving back alone Patients who are allergic to the prescribed medicines

Sites / Locations

  • Dow International Dental College

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Active Comparator

Active Comparator

Placebo Comparator

Arm Label

Tramadol

Naproxen Sodium

Placebo

Arm Description

Group A will receive premedication of Oral tramadol 100mg,

Group B will receive premedication of oral naproxen sodium 550mg.

Group C, will be the control group and no active preoperative medication will be given to these patients.

Outcomes

Primary Outcome Measures

Local Anesthesia Efficacy
Change in pain will be assessed after administration of inferior alveolar nerve block and during access opening on a visual analogue scale of 0-10 ," 0 being no pain", "10 being worst pain"
Postoperative pain
Change in pain will be assessed after cleaning and shaping till #25 k file on a visual analogue scale of 0-10, "0 being no pain and 10 being worst pain"

Secondary Outcome Measures

Adverse effects of Medications
Nausea, Headache, Dizziness, Vertigo will be recorded as experienced or not experienced

Full Information

First Posted
July 19, 2023
Last Updated
September 3, 2023
Sponsor
Dow University of Health Sciences
search

1. Study Identification

Unique Protocol Identification Number
NCT05982392
Brief Title
Effect of Preoperative Tramadol and Naproxen Sodium on Post Operative Pain
Official Title
Effect of Preoperative Tramadol and Naproxen Sodium on Efficacy of Local Anesthesia and Post-operative Pain in Patients With Symptomatic Irreversible Pulpitis
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Completed
Study Start Date
March 1, 2023 (Actual)
Primary Completion Date
August 15, 2023 (Actual)
Study Completion Date
August 15, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Dow University of Health Sciences

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The goal of this clinical trial is to compare in Tramadol, Naproxen sodium and Placebo in participants presenting with irreversible pulpitis in their mandibular posterior teeth. The main question[s] it aims to answer are: Local anesthetic efficacy and . Postoperative pain. Participants will receive premedication treatments 60 minutes prior to the local anesthesia administration. Researchers will compare Tramadol, Naproxen sodium and Placebo to evaluate their effects on Inferior alveolar nerve block efficacy and Postoperative pain.
Detailed Description
The adult participants who report in out-patient department (OPD) of Operative Dentistry at Dow International Dental College with the symptoms of irreversible pulpitis will be screened for the participation in the study. A detailed history will be taken which will be followed by clinical examination and complemented with sensibility testing with Endo Ice or electric pulp test. Radiographic analysis will also be done to confirm the diagnosis to assess for factors pertaining to exclusion and inclusion criteria. Verbal and written informed consent will be taken from all the participants. Randomization: The participants will be randomly divided into 3 groups by envelope method. Group A will receive premedication of Oral tramadol 100mg, Group B will receive premedication of oral naproxen 550mg. Both medicines will be given 60 minutes prior to the local anesthesia administration. The third group, Group C, will be the control group and no active preoperative medication will be given to these participants. A placebo will be given to these participants. These medications will be given as a single intervention only. Blinding: Clinician and participants both will be blind to the medicine given to the participants. Participants will be allowed to pick envelopes and a paramedical staff will be trained in giving medication to the participants. Pain scores will be recorded by asking the participant to rate their pain on a scale ranging from 0 to 10 before medication and then after 15 minutes, 30 minutes and 60 minutes of administering the premedication. Pain score will also be recorded after 10 minutes of the administration of Inferior alveolar nerve block (IANBs) and buccal nerve block & during deroofing process of chamber opening. Two cartridges of Lidocaine 1.8 ml having a concentration of 1:100,000 of Epinephrine will be used for administration of regional anesthesia. Access opening will be performed under rubber dam isolation with a Mani number 245 bur in a high-speed hand piece with copious water irrigation. Sodium hypochlorite (5.25%) will be used as a standard root canal irrigation solution.Pulpectomy will be performed with Mani K-files (8-25) till respective working lengths of the teeth under study. To assess the post-operative pain, a proforma and pain intensity scale will be provided to the participants for self recording at 6, 24, 48 and 72 hours after the procedure. The participants will return the proforma to an intern on 3rd day to be assessed by an intern supervised by the principal investigator. (For this research, "The investigators will be offering As per need analgesic for breakthrough pain. Participants will be offered brufen 400mg as needed. The participants will be advised to mark breakthrough pain on VAS at the time of taking medicine). The participants will also be monitored for the adverse effects of these medications (nausea, vomiting, dizziness, drowsiness) as a secondary outcome .at above-mentioned time-intervals.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Symptomatic Irreversible Pulpitis, Post Operative Pain
Keywords
Tramadol, Naproxen Sodium, Placebo

7. Study Design

Primary Purpose
Prevention
Study Phase
Phase 2, Phase 3
Interventional Study Model
Parallel Assignment
Model Description
The participants will be randomly divided into 3 groups by envelope method. Group A will receive premedication of Oral tramadol 100mg, Group B will receive premedication of oral naproxen sodium 550mg. Both medicines will be given 60 minutes prior to the local anesthesia administration. The third group, Group C, will be the control group and no active preoperative medication will be given to these participants. A placebo will be given to these participants. These medications will be given as a single intervention only.
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Masking Description
Clinician and participants both will be blind to the medicine given to the participants. Participants will be allowed to pick envelopes and a paramedical staff will be trained in giving medication to the participants. Procedure will be performed by an intern (who is not part of the research)Investigator is the Outcome Assessor.
Allocation
Randomized
Enrollment
47 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Tramadol
Arm Type
Active Comparator
Arm Description
Group A will receive premedication of Oral tramadol 100mg,
Arm Title
Naproxen Sodium
Arm Type
Active Comparator
Arm Description
Group B will receive premedication of oral naproxen sodium 550mg.
Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
Group C, will be the control group and no active preoperative medication will be given to these patients.
Intervention Type
Drug
Intervention Name(s)
Tramadol
Other Intervention Name(s)
Tramal tablet
Intervention Description
Tramadol 100mg will be given 60 minutes before start of procedure.
Intervention Type
Drug
Intervention Name(s)
Naproxen Sodium
Other Intervention Name(s)
Synflex 550mg
Intervention Description
Naproxen sodium 550mg will be given 60 minutes before start of procedure.
Intervention Type
Drug
Intervention Name(s)
Placebo
Other Intervention Name(s)
Surbex Z
Intervention Description
Placebo will be given 60 minutes before start of procedure.
Primary Outcome Measure Information:
Title
Local Anesthesia Efficacy
Description
Change in pain will be assessed after administration of inferior alveolar nerve block and during access opening on a visual analogue scale of 0-10 ," 0 being no pain", "10 being worst pain"
Time Frame
10minutes,20minutes
Title
Postoperative pain
Description
Change in pain will be assessed after cleaning and shaping till #25 k file on a visual analogue scale of 0-10, "0 being no pain and 10 being worst pain"
Time Frame
6 hours, 24 hours,48 hours, 72hours
Secondary Outcome Measure Information:
Title
Adverse effects of Medications
Description
Nausea, Headache, Dizziness, Vertigo will be recorded as experienced or not experienced
Time Frame
6hours, 24hours

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: ASA I and ASA II individuals who are between the ages of 18 and 60 years. Patients who have been diagnosed with symptomatic irreversible pulpitis (with either a normal periapex or symptomatic apical periodontitis). Patients who score moderate to severe (4-10) on a preoperative visual analogue scale (VAS= 1-10). Mandibular permanent premolar and molars. Exclusion Criteria: Patients who had taken painkillers or narcotics in the previous 12 hours Patients suffering from severe pain because of traumatic occlusion. Teeth with extensive damage, calcified canals, root resorption, and an open apex. Previously root canal treated teeth. Medically compromised patients (ASA-III and above) Those with special communication needs or who do not understand Urdu or English language. Pregnant and lactating women Individual patients who will be driving back alone Patients who are allergic to the prescribed medicines
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Tayyaba Tahira, BDS FCPS
Organizational Affiliation
Dow International Dental College, Dow University of Health Sciences
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Farah Naz, BDS FCPS
Organizational Affiliation
Dow International Dental College, Dow University of Health Sciences
Official's Role
Study Director
Facility Information:
Facility Name
Dow International Dental College
City
Karachi
State/Province
Sindh
ZIP/Postal Code
75500
Country
Pakistan

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
Only investigators and co-investigators of this study will be able to access to participants' personal data. Ownership of the data will remain with the principal investigator and Department of Operative Dentistry, Dow International Dental College

Learn more about this trial

Effect of Preoperative Tramadol and Naproxen Sodium on Post Operative Pain

We'll reach out to this number within 24 hrs